JPMORGAN CHASE & CO - COCRYSTAL PHARMA INC ownership

COCRYSTAL PHARMA INC's ticker is COCP and the CUSIP is 19188J300. A total of 34 filers reported holding COCRYSTAL PHARMA INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of COCRYSTAL PHARMA INC
ValueSharesWeighting
Q3 2022$1,000
-66.7%
3,995
-51.7%
0.00%
Q2 2022$3,000
-50.0%
8,265
-19.5%
0.00%
Q1 2022$6,000
-84.6%
10,261
-82.9%
0.00%
Q4 2021$39,000
+3800.0%
59,959
+5155.0%
0.00%
Q3 2021$1,000
-50.0%
1,141
-18.7%
0.00%
Q1 2021$2,0001,4040.00%
Other shareholders
COCRYSTAL PHARMA INC shareholders Q2 2022
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 6,110,657$7,638,0001.08%
Altium Capital Management LP 776,000$970,0000.22%
Alyeska Investment Group, L.P. 2,750,100$3,438,0000.04%
Virtu Financial LLC 116,625$146,0000.01%
Parallel Advisors, LLC 184,708$231,0000.01%
Renaissance Technologies 2,593,933$3,242,0000.00%
CIM, LLC 11,000$12,0000.00%
Western Wealth Management, LLC 19,115$24,0000.00%
Mariner, LLC 200,055$250,0000.00%
BRIGHTON JONES LLC 36,000$45,0000.00%
View complete list of COCRYSTAL PHARMA INC shareholders